勘误：褪黑激素靶向 NF-κB/AP-2β 信号增强顺铂在肝癌细胞中的抗肿瘤活性

IF 3.6 3区医学 Q2 ONCOLOGY

American journal of cancer research Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI:10.62347/SUKI5933

Jiaojiao Hao, Zhenglin Li, Changlin Zhang, Wendan Yu, Zhipeng Tang, Yixin Li, Xu Feng, Yue Gao, Quentin Liu, Wenlin Huang, Wei Guo, Wuguo Deng

引用次数: 0

摘要

[此处更正了第 7 卷第 13 页的文章，PMID：28123844]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Erratum: Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells.

[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American journal of cancer research ONCOLOGY-

自引率

3.80%

发文量

263

期刊介绍： The American Journal of Cancer Research (AJCR) (ISSN 2156-6976), is an independent open access, online only journal to facilitate rapid dissemination of novel discoveries in basic science and treatment of cancer. It was founded by a group of scientists for cancer research and clinical academic oncologists from around the world, who are devoted to the promotion and advancement of our understanding of the cancer and its treatment. The scope of AJCR is intended to encompass that of multi-disciplinary researchers from any scientific discipline where the primary focus of the research is to increase and integrate knowledge about etiology and molecular mechanisms of carcinogenesis with the ultimate aim of advancing the cure and prevention of this increasingly devastating disease. To achieve these aims AJCR will publish review articles, original articles and new techniques in cancer research and therapy. It will also publish hypothesis, case reports and letter to the editor. Unlike most other open access online journals, AJCR will keep most of the traditional features of paper print that we are all familiar with, such as continuous volume, issue numbers, as well as continuous page numbers to retain our comfortable familiarity towards an academic journal.